Testing As Prevention of Resistance in Bacteria Causing Sexually Transmitted Infections-A Population-Based Model for Germany

Overview

Journal Antibiotics (Basel)

Specialty Pharmacology

Date 2021 Aug 27

PMID 34438979

Citations 2

Authors

Andreas Hahn

Hagen Frickmann

Ulrike Loderstadt

Affiliations

Soon will be listed here.

Abstract

Prescribed antibiotic treatments which do not match the therapeutic requirements of potentially co-existing undetected sexually transmitted infections (STIs) can facilitate the selection of antibiotic-drug-resistant clones. To reduce this risk, this modelling assessed the potential applicability of reliable rapid molecular test assays targeting bacterial STI prior to the prescription of antibiotic drugs. The modelling was based on the prevalence of three bacterial STIs in German heterosexual and men-having-sex-with-men (MSM) populations, as well as on reported test characteristics of respective assays. In the case of the application of rapid molecular STI assays for screening, the numbers needed to test in order to correctly identify any of the included bacterial STIs ranged from 103 to 104 for the heterosexual population and from 5 to 14 for the MSM population. The number needed to harm-defined as getting a false negative result for any of the STIs and a false positive signal for another one, potentially leading to an even more inappropriate adaptation of antibiotic therapy than without any STI screening-was at least 208,995 for the heterosexuals and 16,977 for the MSM. Therefore, the screening approach may indeed be suitable to avoid unnecessary selective pressure on bacterial causes of sexually transmitted infections.

Citing Articles

Development of a DNA-Based Lateral Flow Strip Membrane Assay for Rapid Screening and Genotyping of Six High-Incidence STD Pathogens.

Choi G, Song K, Balasaheb Nimse S, Kim T Biosensors (Basel). 2024; 14(5).

PMID: 38785734 PMC: 11118844. DOI: 10.3390/bios14050260.

Modelling of doxycycline-based prevention of bacterial sexually transmitted infections in comparison to condom-based and test-based prevention.

Hahn A, Frickmann H, Loderstadt U Eur J Microbiol Immunol (Bp). 2024; 14(1):50-58.

PMID: 38289395 PMC: 10895362. DOI: 10.1556/1886.2023.00059.

References

Eyre D, Sanderson N, Lord E, Regisford-Reimmer N, Chau K, Barker L . Gonorrhoea treatment failure caused by a strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018. Euro Surveill. 2018; 23(27). PMC: 6152157. DOI: 10.2807/1560-7917.ES.2018.23.27.1800323. View

de Vries H, De Barbeyrac B, de Vrieze N, Viset J, White J, Vall-Mayans M . 2019 European guideline on the management of lymphogranuloma venereum. J Eur Acad Dermatol Venereol. 2019; 33(10):1821-1828. DOI: 10.1111/jdv.15729. View

Loftie-Eaton W, Bashford K, Quinn H, Dong K, Millstein J, Hunter S . Compensatory mutations improve general permissiveness to antibiotic resistance plasmids. Nat Ecol Evol. 2017; 1(9):1354-1363. PMC: 5649373. DOI: 10.1038/s41559-017-0243-2. View

Haversath J, Garttner K, Kliem S, Vasterling I, Strauss B, Kroger C . Sexual Behavior in Germany. Dtsch Arztebl Int. 2017; 114(33-34):545-550. PMC: 5596148. DOI: 10.3238/arztebl.2017.0545. View

Unemo M, Ross J, Serwin A, Gomberg M, Cusini M, Jensen J . 2020 European guideline for the diagnosis and treatment of gonorrhoea in adults. Int J STD AIDS. 2020; :956462420949126. DOI: 10.1177/0956462420949126. View

Brook G . The performance of non-NAAT point-of-care (POC) tests and rapid NAAT tests for chlamydia and gonorrhoea infections. An assessment of currently available assays. Sex Transm Infect. 2015; 91(8):539-44. DOI: 10.1136/sextrans-2014-051997. View

Lanjouw E, Ouburg S, de Vries H, Stary A, Radcliffe K, Unemo M . 2015 European guideline on the management of Chlamydia trachomatis infections. Int J STD AIDS. 2015; 27(5):333-48. DOI: 10.1177/0956462415618837. View

San Millan A . Evolution of Plasmid-Mediated Antibiotic Resistance in the Clinical Context. Trends Microbiol. 2018; 26(12):978-985. DOI: 10.1016/j.tim.2018.06.007. View

Canton R, Morosini M . Emergence and spread of antibiotic resistance following exposure to antibiotics. FEMS Microbiol Rev. 2011; 35(5):977-91. DOI: 10.1111/j.1574-6976.2011.00295.x. View

10.

Beceiro A, Tomas M, Bou G . Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world?. Clin Microbiol Rev. 2013; 26(2):185-230. PMC: 3623377. DOI: 10.1128/CMR.00059-12. View

11.

Nwokolo N, Dragovic B, Patel S, Tong C, Barker G, Radcliffe K . 2015 UK national guideline for the management of infection with Chlamydia trachomatis. Int J STD AIDS. 2015; 27(4):251-67. DOI: 10.1177/0956462415615443. View

12.

Frickmann H . Diversification of the prevention of sexually transmitted infections. Future Microbiol. 2020; 14:1465-1468. DOI: 10.2217/fmb-2019-0261. View

13.

Goldenberg S, Finn J, Sedudzi E, White J, Tong C . Performance of the GeneXpert CT/NG assay compared to that of the Aptima AC2 assay for detection of rectal Chlamydia trachomatis and Neisseria gonorrhoeae by use of residual Aptima Samples. J Clin Microbiol. 2012; 50(12):3867-9. PMC: 3502981. DOI: 10.1128/JCM.01930-12. View

14.

Smith E . Ampicillin in the treatment of "penicillin-resistant" gonorrhea. Mil Med. 1966; 131(4):345-7. View

15.

Jansen K, Steffen G, Potthoff A, Schuppe A, Beer D, Jessen H . STI in times of PrEP: high prevalence of chlamydia, gonorrhea, and mycoplasma at different anatomic sites in men who have sex with men in Germany. BMC Infect Dis. 2020; 20(1):110. PMC: 7007644. DOI: 10.1186/s12879-020-4831-4. View

16.

Fusca L, Hull M, Ross P, Grennan T, Burchell A, Bayoumi A . High Interest in Syphilis Pre-exposure and Post-exposure Prophylaxis Among Gay, Bisexual and Other Men Who Have Sex With Men in Vancouver and Toronto. Sex Transm Dis. 2020; 47(4):224-231. PMC: 7077973. DOI: 10.1097/OLQ.0000000000001130. View

17.

Frickmann H, Podbielski A, Kreikemeyer B . Resistant Gram-Negative Bacteria and Diagnostic Point-of-Care Options for the Field Setting during Military Operations. Biomed Res Int. 2018; 2018:9395420. PMC: 6020508. DOI: 10.1155/2018/9395420. View

18.

Fifer H, Saunders J, Soni S, Sadiq S, Fitzgerald M . 2018 UK national guideline for the management of infection with . Int J STD AIDS. 2019; 31(1):4-15. DOI: 10.1177/0956462419886775. View

19.

Park J, Stafylis C, Pearce D, Taylor J, Little S, Kojima N . Interest, Concerns, and Attitudes Among Men Who Have Sex With Men and Health Care Providers Toward Prophylactic Use of Doxycycline Against Chlamydia trachomatis Infections and Syphilis. Sex Transm Dis. 2021; 48(9):615-619. PMC: 8521638. DOI: 10.1097/OLQ.0000000000001395. View

20.

Tsai A, Dueger E, Macalino G, Montano S, Tilley D, Mbuchi M . The U.S. military's Neisseria gonorrhoeae resistance surveillance initiatives in selected populations of five countries. MSMR. 2013; 20(2):25-7. View